"While the rescinded grant is undoubtedly a setback, it also sharpens our focus on the solid foundation already established ...

Viking Therapeutics offers leaner operations, lower complexity, faster trial execution, and less execution risk. Learn more ...

A Massachusetts-based wound care and sports medicine company announced plans for its brand-new biomanufacturing facility ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

Walter Isaacson, ‘Elon Musk’ author, Perella Weinberg Partners advisory partner and Tulane professor, joins 'Squawk Box' to ...

Announcing the $256 million deal, the New York-based biotech firm vowed to comply with 23andMe’s privacy policy, which was a ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

FBT ETF launched 19 years ago and has delivered exceptional returns compared to the broader Health Care sector. Read why FBT ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

Oslo, 20 May 2025. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of Hans Peter ...

Fierce 15 nominations are open! We're searching for the most innovative, resourceful and visionary biotechs leading the way ...

In its announcement of the acquisition, Regeron claimed it would ensure that customers’ personal data including genetic and ...